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Aspalathus linearis (Burm.f.) Dahlg. (Fabaceae, Tribe Crotalarieae), an endemic South African fynbos species, is cultivated to produce the
well-known herbal tea, rooibos. It is currently sold in more than 37 countries with Germany, the Netherlands, the United Kingdom, Japan and the
United States of America representing 86% of the export market in 2010. Its caffeine-free and comparatively low tannin status, combined with its
potential health-promoting properties, most notably antioxidant activity, contributes to its popularity. First marketed in 1904 in its fermented
(oxidised) form, green rooibos is a new product recently on the market. The utilisation of rooibos has also moved beyond a herbal tea to
intermediate value-added products such as extracts for the beverage, food, nutraceutical and cosmetic markets. Its potential as a
phytopharmaceutical, shown in recent scientific studies, has not yet been exploited. This review focuses on past and current research aimed at
enhancing the value of rooibos herbal tea as a specialised, niche product and expanding its value-adding potential against the background of its
traditional use and the current market. The focus falls specifically on aspects such as composition, processing, quality and rooibos as food and
potential medicine.
© 2011 SAAB. Published by Elsevier B.V. All rights reserved.
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The genus Aspalathus (Fabaceae, Tribe Crotalarieae)
comprises more than 270 species of which most are endemic
to the Cape Floristic Region (Dahlgren, 1968). Rooibos tea,
produced from A. linearis (Burm.f.) Dahlg., had no commercial
value at the beginning of the 20th century, but today it is a well-
known herbal tea, enjoyed in more than 37 countries. A recent
report by the Swiss Business Hub South Africa (Anon, 2007)
stated that ‘Rooibos appears to be headed towards becoming the
second most commonly consumed beverage tea ingredient in
the world after ordinary tea (Camellia sinensis)’. In South⁎ Corresponding author at: Post-Harvest and Wine Technology Division,
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doi:10.1016/j.sajb.2011.07.004Africa it is well established, enjoying popularity amongst an
estimated 10.9 million households (data supplied by SA
Rooibos Council (SARC), 2011).
Several reviews dealing with rooibos have been published
over the years since Cheney deemed it of too insignificant
economic importance as a beverage to include it in a review of
the biology and economics of the global beverage industry
(Cheney, 1947). A different point of view, appreciating its value
as a beverage with wide appeal, was later offered (Cheney and
Scholtz, 1963). In her review, Morton (1983) campaigned for
wider recognition and better distribution of rooibos in the
United States of America. It continued to fascinate researchers
and recent reviews cover diverse topics such as the development
path of rooibos (Rampedi and Olivier, 2008), bioactivity and
potential health benefits (Joubert et al., 2008a; Marnewick,
2010; McKay and Blumberg, 2007), and production, processing
and quality aspects of rooibos tea and related products (Joubert
and Schulz, 2006; Joubert et al., 2008a). The relevance of thets reserved.
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bioavailability and potential herb–drug interactions were
addressed by Joubert et al. (2009a). The major focus of the
present review will be on past and current research aimed at
enhancing the value of rooibos herbal tea as a specialised, niche
product and expanding its value-adding potential against the
background of its traditional use and the current market. Within
the context of enhancing the value of rooibos, aspects such as
composition, processing, quality, and rooibos as food and
potential medicine (phytopharmaceutical) will be discussed.
2. Utilisation of Aspalathus linearis
The first person to realise the commercial potential of
rooibos as a herbal tea was Benjamin Ginsberg, a merchant of
Clanwilliam, who started marketing it in 1904. He obtained the
tea from descendants of the Khoi who crudely processed it
during the warm summer months. It was, however, only by
1930 that the agricultural value of rooibos was recognised by a
medical practitioner and nature lover, P. Le Fras Nortier of
Clanwilliam. His early cultivation experiments, carried out with
the help of local farmers, O. Bergh and H. Riordan (Anon,
1985), laid the foundation for the industry. Growing participa-
tion of other farmers in rooibos production and increased
demand over the years expanded the area under cultivation to
36 000 ha (Pretorius, 2007), with production mainly concen-Fig. 1. Production areas of Aspalathus linearis in and around the Gretrated in the Clanwilliam area (Fig. 1). Since expansion has
threatened biodiversity of the Greater Cederberg Biodiversity
Corridor, SARC in partnership with CapeNature, formed the
Rooibos Biodiversity Initiative. One of its aims was to
undertake a joint planning process for expansion to minimise
loss of threatened natural habitat (Pretorius, 2007). Following
this, a current initiative of SARC is to establish the Right
Rooibos Sustainability Standard (http://sarooibos.org.za).
In the early years, different Aspalathus species and ecotypes,
naturally occurring in the Cederberg mountain area, were used
to produce rooibos tea (Dahlgren, 1968, 1988). Today only the
so-called red type or Rocklands type, originally from the
Pakhuis Pass area, is of commercial importance. The red type is
divided into the selected, improved Nortier type (cultivated;
Fig. 2), and the Cederberg type (wild-growing). The latter type
has broader and coarser leaves than the Nortier type (Morton,
1983). Characteristics associated with the cultivated type are
bright green, needle-like leaves on straight, slender branches
with relatively short internodes. The leaves should turn red-
brown when bruised (Dahlgren, 1968).
Tea is also sometimes made from small quantities of a
closely related species, A. pendula Dahlg. and several wild
types of A. linearis (Van Heerden et al., 2003). The grey, black
and red-brown types were harvested in the wild, processed and
sold to the Rooibos Tea Control Board until 1966, after which
the marketing of the grey and black types were discontinued dueater Cederberg Biodiversity Corridor (map supplied by SARC).
Fig. 2. Rooibos plantation in the Clanwilliam area.
Table 1
Local, export and total sales of rooibos tea (tons) from 1970 to 1992 (data
compiled from Anon, 1992).
Year Local Export Total
1970 1277 33 1310
1971 1322 39 1361
1972 1209 49 1258
1973 1088 64 1152
1974 1179 62 1242
1975 1530 86 1616
1976 1440 104 1544
1977 2572 74 2646
1978 3224 140 3363
1979 2186 95 2281
1980 2147 86 2233
1981 2745 140 2885
1982 2086 132 2218
1983 2588 142 2730
1984 2600 177 2777
1985 2378 268 2646
1986 2772 373 3146
1987 2999 316 3315
1988 3123 368 3491
1989 3033 260 3292
1990 3344 432 3776
1991 3292 505 3796
1992 3475 511 3986
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(1953) the infusion of the black type was not typically red-
brown, nor was the flavour characteristic. Recent assessment of
wild types demonstrated morphological (Malgas et al., 2010),
genetic (Malgas et al., 2010), chemical (Van Heerden et al.,
2003) and ecological (Hawkins et al., 2011) variation.
Wild rooibos re-gained prominence as a source of income in
recent years. Small-scale producer organisations in the Cederberg
(Wupperthal) and Southern Bokkeveld (Heiveld) supply wild
harvested rooibos under organic and fair-trade certification to niche
markets abroad (Nel et al., 2007).Wild rooibos comprises ca 2–5%
of the annual production of 40 tons rooibos by the Heiveld Co-
operative (Patrickson et al., 2008). Wupperthal's production of
wild-harvested rooibos is approximately 10 tons (Binns et al.,
2007).
3. Rooibos tea market
The early years of the industry saw a growing demand due to a
shortage ofOriental tea (Camellia sinensis) as a result of the Second
WorldWar, followed by market collapse in the years after the war.
The Clanwilliam Tea Co-operative Company was subsequently
established in 1948 to improvemarketing conditions for rooibos tea
producers. However, a further market decline made rooibos
production uneconomical by 1953/54, which led to the establish-
ment of the Rooibos Tea Control Board (later known as the
Rooibos Tea Board), at the request of producers, to stabilise the
industry. It started functioning on 6 December 1954 with the
objectives, amongst others, to regulate themarketing of rooibos and
ensure price stabilisation. Total sales were only 524 tons in 1955.
When the Rooibos Tea Board was abolished on 1 October 1993
total sales were more than 4000 tons. The entry of new marketing
companies and access to new markets resulted in strong growth in
sales during subsequent years.With the abolishment of theRooibosTea Board, no organisation dealing with matters of mutual concern
existed. This changed in 2005 when SARC was established to
coordinate activities relating to generic marketing, research and
development, and sustainable natural resource management.
From the modest beginning of Benjamin Ginsberg's
marketing effort in 1904 rooibos has become a global product,
contributing an estimated R120 million in foreign earnings in
2010 (data supplied by SARC, 2011). Table 1 gives a snapshot
of sales (local, export and total) for a 23-year period (1970–
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(Anon, 1992). In 2010, the international market was 5633 tons
(data supplied by SARC) compared to 750 tons in 1993 (Anon,
1994). During the past 10 years exports peaked at 5964 tons in
2003 and at 7176 tons in 2007 (Fig. 3). Factors contributing to
the decline in export during the past 3 years were global
economic uncertainty and a strong Rand (Anon, 2011a).
The major export market through the years remained
Germany (previously West Germany), where it was first sold
in 1961 as ‘Rotbuschtee’ or ‘Massai-Tee’ (Joubert and Schulz,
2006). Exports to Germany as a percentage of the total peaked
in 2003 at 76%, thereafter declining to 43% in 2010 (Table 2).
During the past 10 years exports to the United States of America
(USA) increased more than five-fold from 67 tons to 346 tons.
During the same period, exports to the United Kingdom (UK)
increased 10-fold from 75 tons to 772 tons. Consumer aware-
ness of rooibos overseas has been boosted, amongst others, by a
fictional character, the rooibos tea-drinking Mma Ramotswe, in
the ‘The No. 1 Ladies’ Detective Agency’ novels (Goddard,
2005; Jaganath and Crozier, 2010).
The domestic market for rooibos showed a steady increase
over the years. In 1984 sales were 2600 tons (Table 1) and
rooibos had a 12% share of the domestic tea market (Anon,
2001). By 2010 its market share had more than doubled,
representing approximately 23% of the tea market with sales
reaching more than 5000 tons with an estimated retail sales
value of R429 million (data supplied by SARC).
Organic production of rooibos still lags behind production of
conventional rooibos. Exports of organic rooibos reached
828 tons in 2010 (Table 3) with Japan the major market at
222 tons followed by Germany, UK, Netherlands and USA
(data from Perishable Products Export Control Board (PPECB),
supplied by SARC). Total exports of green rooibos reached
253 tons in 2010 (Table 3), of which 70% went to Germany.
The only other country that buys substantial quantities is the
Netherlands (16% in 2010). The combined exports of green
rooibos to Japan, USA and UK comprised 12% of the total
volumes for 2010.
A characteristic of the rooibos industry is the cycles of a
shortage in supply, accompanied by high prices, followed by
expansion of production and subsequent over-supply, accom-
panied by low to very low prices. In 2004 producers earned on0
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Fig. 3. Total export volumes for rooibos during the period 1999–2010
(data from PPECB, supplied by SARC).average an all-time record of R16.00/kg, but it was followed by
a steady decline to R4.50/kg in 2010, a farm gate value last
received in 1999 (data supplied by SARC). This negatively
affects the economic viability of the crop. Droughts usually
contribute to the shortages. In 1984, following overproduction
during that production season and the two preceding seasons,
the amount of stocks in reserve was ca 10,000 tons (Joubert,
1994) at a stage when total annual sales were less than
3000 tons (Table 1). By 1994, the increased demand could not
be met due to a shortage in production (Anon., 1994), yet in
1996 the situation had again changed drastically, i.e. over-
production and low prices. Similar situations have occurred
since then, with the most recent record harvests in 2006
(10,000 tons), 2007 (14,000 tons) and 2008 (18,000 tons),
respectively, leading to very low prices (Genis, 2008). The
production shortage, predicted for 2011, will be the first since
2003 (Swartz, 2011).
4. Geographical indication (GI)
Opportunistic trade marking of the term ‘rooibos’ in 1994 in
the USA, which prevented the free use of this generic term in
marketing and the subsequent legal battle to reclaim the name
for South Africa, has given impetus to the development of a
Geographic Indication (GI) for rooibos (Gerz and Bienabe,
2006). It is mainly seen as a defensive measure against possible
cultivation outside South Africa and to protect intellectual
property rights. A GI is a label that is reserved for products
which acquire their characteristic and defining qualities as a
result of their geographical location, e.g. Champagne, Tequila
or Parma Ham (Grazioli, 2002). In this way producers can
distinguish their product based on its specific origin-related
characteristics.
The rigorous process of GI certification means that strict
quality criteria, linked to its geographic cultivation, must be
implemented. Aspalathin, as an unique rooibos phenolic
constituent, is also under consideration as a defining parameter.
It is believed that these quality criteria will have a positive effect
on quality control and marketing (Anon, 2010). Results of an
ARC project on the development of the sensory wheel and
objective quality criteria (Sections 8.1 and 8.2), undertaken for
SARC, will be critical for the certification and required quality
control processes.
5. Value addition
The rooibos industry, characterised by bulk sales as opposed
to the sale of retail packaged products to international markets,
would greatly benefit from value-addition (Anon, 2010). Based
on the number of patents filed (Kaplan, 2009), protection of
intellectual property for new applications and/or processes
relating to rooibos were considered worth-while. Japan has been
especially active in this regard.
The first value-addition was done by A. Theron who brought
an extensive cosmetic care range containing rooibos extract to
the market (Joubert and Schulz, 2006). Her range of products is
distributed to 34 countries (Anon, 2010). Scientific studies in
Table 2
Major export countries with % of export to each from 2001 to 2010 (data from PPECB, supplied by SARC).
Country 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010
Germany 57.50 64.91 75.88 74.01 63.25 56.90 54.83 50.76 48.17 42.82
Netherlands 14.89 15.75 7.63 9.47 13.48 13.54 10.88 10.95 15.25 17.32
United Kingdom 1.85 3.05 2.84 2.74 5.75 7.22 7.35 11.37 12.56 13.70
Japan 14.94 7.78 7.95 5.21 5.12 5.30 5.76 3.78 6.07 6.34
United States of America 1.72 2.07 2.06 5.01 4.07 6.56 5.34 4.96 4.45 6.14
Other 9.10 6.43 3.63 3.56 8.33 10.47 15.85 18.19 13.50 13.69
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of rooibos extract are, however, very limited. The role of
aspalathin, the major rooibos flavonoid and antioxidant, has not
yet been clarified. Poor penetration of the skin by aspalathin has
been demonstrated by Huang et al. (2008a). An anti-wrinkle
effect was demonstrated for a formulation containing rooibos
and tea (Camellia sinensis) (Chuarienthong et al., 2010). Since
rooibos extract was not tested alone it is not possible to make
conclusions about its efficacy as an anti-wrinkle agent.
According to Glynn (2010) the topical application of an herbal
mixture, containing green rooibos extract, alleviates male
pattern baldness. A recent US patent application deals with
the protective effect of rooibos extract against hair colour loss
(Joppe et al., 2009).
Rooibos extracts, produced locally and abroad, are considered
intermediate value-added products in the value chain. Apart from
cosmetics, final product applications include functional foods and
beverages, as well as nutraceuticals. Rooibos is also finding
application in pet food and pet skin care products (Anon, 2010).
One of the earliest applications of rooibos extract and its
volatile fraction was as a flavour ingredient of yogurt by the
then Van Riebeeck Dairies when the rooibos instant tea powder
was first developed (Joubert, 1984). At that stage the use of
rooibos as functional ingredient was not yet realised. Neither the
instant rooibos tea nor the yogurt reached the market. It was
only in 2000 that the manufacture of rooibos powdered extract
by a South African company became a reality, when changing
consumer attitudes towards natural products made it a viable
value-addition option.
The types of rooibos extract and the raw material from which
it is produced depends on the final application. A broad
distinction can be made between extracts from fermented and
green rooibos. Fermented rooibos provides the bulk of the
material for production of extracts, used predominantly inTable 3
Exports of organic and green rooibos (tons) from 2003 to 2010 (data from
PPECB, supplied by SARC).
Year Organic Green
2003 648 83
2004 382 60
2005 624 64
2006 386 112
2007 756 74
2008 840 87
2009 791 145
2010 828 253beverages and functional foods. Its aroma extract is used to
flavour beverages (Anon, 2010).
Some of the food and beverage products currently on the
market that contain rooibos extract are yogurt, drinking yogurt,
ready-to-drink iced tea, jam and ‘instant cappuccino’. Labelling of
the rooibos-containing yogurt, carrying the Cancer Association of
South Africa Smart Choice emblem, makes extensive use of
potential functional properties of rooibos. The drinking yogurt
also refers to the ‘active ingredient’ of rooibos, but no specific
‘active ingredient’ is mentioned. It must be assumed that the
‘active ingredient’ is the rooibos solids as no single compound in
rooibos is solely responsible for its antioxidant and anti-cancer
properties (Joubert et al., 2009a; Snijman et al., 2007).
In many instances, rooibos is only one of several herbal and
fruit ingredients in beverages (Anon, 2009a, b). Functional
drinks launched in USA and Italy in 2009 contain, amongst
others, rooibos and pomegranate. Another drink, launched in
the same year in Japan by a major soft drink company contains,
apart from rooibos as main ingredient, also green tea, Japanese
citrus fruit peel, kumazasa (bamboo), pure tea, fennel, turmeric
and hawthorn extract.
Green rooibos, first produced as part of an ARC research
project during the 1990s to achieve higher antioxidant levels, is
used as a tea and for preparation of extracts for the food,
cosmetic and functional beverage markets. The higher levels of
flavonoids (antioxidants) in green rooibos, combined with its
caffeine-free status contribute to its popularity in tea blends
(Cosgrove, 2010) and cosmetic products (Otto et al., 2003;
Tiedtke and Marks, 2002). Aspalathin-enriched extracts can be
prepared from green rooibos as this compound is present in high
levels (Manley et al., 2006; Schulz et al., 2003). The level of
enrichment greatly depends on extraction conditions and level
of purification. According to a patented process, enrichment is
achieved with organic solvents (Grüner-Richter et al., 2008).
The tan to greenish coloured extract was initially developed for
the cosmetic market (B. Weinreich, Raps & Co, Germany; pers.
comm.). A Japanese company also produces an orange coloured
aspalathin-enriched extract, specified to contain a minimum of
20% aspalathin. This extract is destined for the supplement
market (H. Hata, Tama Biochemical Co., Japan; pers. comm.).
Pharmaceutical product applications of rooibos have not yet
been exploited, but according to the report by Kaiser Associates
(Anon, 2010) opportunities are likely to emerge as a result of the
trend towards phytopharmaceuticals. Rooibos extracts, usually
combined with other ingredients, are available in pill form, but
these products fall in the category of dietary supplements.
Recent research has underscored the potential of aspalathin and
Table 4
Contents of major phenolic compounds in green and fermented Aspalathus linearis plant materiala (means±SD; g/100 g dry matter).
Structures Compounds Green (n=3) Fermented (n=3)
Dihydrochalcones
aspalathin (R1=OH; R2=C-glucosyl) 2.559±0.699 0.421±0.017
nothofagin (R1=C-glucosyl; R2=OH) 0.251±0.230 0.040±0.022
Flavones
orientin (R1=C-glucosyl; R2, R4=OH; R3=H) 0.263±0.087 0.202±0.026
iso-orientin (R1=H; R2, R4=OH; R3=C-glucosyl) 0.450±0.163 0.329±0.049
vitexin (R1=C-glucosyl; R2=OH; R3, R4=H) 0.042±0.020 0.035±0.009
isovitexin (R1, R4=H; R2=OH; R3=C-glucosyl) 0.049±0.029 0.035±0.012
luteolin (R1, R3=H; R2, R4=OH) 0.007±0.006 0.010±0.005
luteolin-7-O-β-D-glucoside (R1, R3=H; R2=O-glucosyl; R4=OH) 0.015±0.008 0.015±0.008
chrysoeriol (R1, R3=H; R2=OH; R4=OCH3) 0.003±0.001 0.007±0.002
Flavonols
quercetin (R1=H; R2, R3=OH) 0.001±0.001 0.010±0.001
hyperoside (R1=H; R2=OH; R3=O-galactosyl) 0.021±0.012 0.016±0.015
rutin (R1=H; R2=OH; R3=O- rutinosyl) 0.245±0.141 0.173±0.016
a Fresh plant material from 3 individual plants was divided in two to produce green (dried whole, 40 °C/12 h) and fermented (shredded; fermented, 38 °C/12 h; dried,
40 °C/12 h) plant material.
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rooibos extract as anti-diabetic agents (Joubert et al., 2010a,b;
Kawano et al., 2009; Mose Larsen et al., 2008). A patent
application for the use of aspalathin in this context was filed in
Japan (K. Yagasaki, TUAT, Japan; pers. comm.), while a PCT
application was filed for the use of rooibos extract as an anti-
diabetic agent (Mose Larsen et al., 2008). It is claimed that
rooibos extract and a heterodimer containing aspalathin,
isolated from rooibos, could be used as a medicament for the
treatment of neurological and psychiatric disorders of the
central nervous system (Bruno and Dimpfel, 2009). Other
opportunities may lie with topical skin products. Two studies
concerning inhibition of COX-2 in mouse skin (Na et al., 2004)
and inhibition of mouse skin tumour promotion (Marnewick
et al., 2005), support the role of the topical application of
rooibos extract in preventing skin cancer.6. Composition
Rooibos is prized as a caffeine-free herbal tea, although traces of
the alkaloid sparteine have been reported (VanWyk and Verdoorn,
1989). Despite beingwell-known as a low tannin tea, ca 50% of the
hot water soluble solids is tannin-like substances (Joubert et al.,
2008a). When compared to black tea (Camellia sinensis), rooibos
contains less tannins (Blommaert and Steenkamp, 1978).Very little
information is available on the structure of the tannins from
rooibos tea, but the dimer, procyanindin B3, the trimer, bis-fisetinidol-(4β,6:4β,8)-catechin, and a pentamer have been
identified (Ferreira et al., 1995).
Rooibos contains two unique phenolic compounds, name-
ly aspalathin (Koeppen and Roux, 1965), a dihydrochalcone
C-glucoside, and aspalalinin (Shimamura et al., 2006), a
cyclic dihydrochalcone. Nothofagin, previously only identi-
fied in the heartwood of Nothofagus fusca (Hillis and Inoue,
1967) and the bark of a Chinese medicinal plant Schoepfia
chinensis (Huang et al., 2008b), is a rare dihydrochalcone
C-glucoside present in rooibos. Other major phenolic com-
pounds present in rooibos include flavones (orientin, isoor-
ientin, vitexin, isovitexin, luteolin, chrysoeriol), flavanones
(dihydro-orientin, dihydro-isoorientin, hemiphlorin) and fla-
vonols (quercetin, hyperoside, isoquercitrin, rutin) (Ferreira
et al., 1995; Koeppen et al., 1962; Marais et al., 2000; Rabe
et al., 1994; Shimamura et al., 2006). Phenolic acids, lignans,
flavone diglycosides, (+)-catechin, a phenylpyruvic acid glyco-
side, the flavonol quercetin-3-O-robinobioside and the couma-
rins, esculetin and esculin, have also been identified (Beltrán-
Debón et al., 2011; Breiter et al., 2011; Krafczyk and Glomb,
2008; Marais et al., 1996; Shimamura et al., 2006).
Fermentation of rooibos plant material to produce the
traditional herbal tea (oxidised form) causes substantial
quantitative changes in its phenolic composition (Table 4,
unpublished data). One of the major changes is oxidation of
aspalathin via its flavanone analogues to isoorientin and orientin
(Koeppen and Roux, 1965; Marais et al., 2000). The oxidation
mechanism was recently further elucidated by Krafczyk and
Fig. 4. Mechanism of aspalathin oxidation (compiled from Krafczyk and Glomb (2008) and Krafczyk et al. (2009)).
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eriodictyol-6-C-glucoside), preferentially formed from aspa-
lathin, oxidises to isoorientin. However, dihydro-orientin ((R)-
and (S)-eriodictyol-8-C-glucoside) does not oxidise directly to
orientin as is the case with dihydro-isoorientin and its flavone,
isoorientin. Orientin forms irreversibly from isoorientin, which
undergoes opening of its vinyl ester structure to form a chalcone
intermediate, which is then converted to orientin. Furthermore,
an aspalathin dimer, partly responsible for browning as a result
of aspalathin oxidation, has also been identified (Krafczyk et al.,
2009).
The potential health benefits of rooibos tea have been linked
to its phenolic content. However, insufficient data are available
on the dietary exposure to rooibos phenolic compounds (Joubert
et al., 2009a). The calculation of rooibos phenolic intake in
populations will allow a study of their association with health
and disease. For this purpose, it is essential to have detailed and
comprehensive information on the nature and quantities of
phenolic compounds in rooibos tea. Increasing interest in
dietary phenolic compounds and their effect on human health
has led to the development of several databases on phenolic
compound contents in foods, such as the USDA Databases onFlavonoids, Phenol-Explorer, and EuroFIR-BASIS (Gry et al.,
2007; Neveu et al., 2010; Pérez-Jiménez et al., 2010). None of
these databases include composition data for rooibos. Current
HPLC methods employed for the analysis of rooibos infusions
and extracts are only suitable for the quantification of some of
the major flavonoids due to the co-elution of various phenolic
constituents. Fingerprinting for authentication/QC and accurate
quantification are therefore not possible. Recently, a new HPLC
method has been developed for the simultaneous quantification
of 16 rooibos phenolic compounds (Beelders et al., 2010a). The
method is currently being used by the ARC to analyse a large
number of infusions prepared from fermented rooibos produc-
tion batches obtained from the 2009, 2010 and 2011 harvest
seasons, to give a snapshot of phenolic variation in rooibos tea
infusions as enjoyed by the consumer. This data would be
suitable for inclusion in food composition databases. In
addition, an even more comprehensive investigation of rooibos
phenolic compounds using 2-dimensional liquid chromato-
graphic techniques is underway (Beelders et al., 2010b).
Very little information on the mineral content of rooibos
infusions is available. Touyz and Smit (1982) showed that an
infusion of fermented rooibos contains 1.29 μg/mL fluoride.
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sodium content of 43.33 μg/mL for the infusion. The toxic
mineral, aluminium, is present in much lower quantities in
fermented and green rooibos infusions than in Camellia sinensis
infusions (Malik et al., 2008). The contents of mineral nutrients
are also fairly low (Joubert et al., 2008a; Malik et al., 2008).
7. Processing
7.1. Tea
Traditional or conventional rooibos is ‘fermented’ to develop
its characteristic red-brown leaf and infusion colour, and
pleasant, slightly sweet flavour. Although modernised, the
processing steps employed today are still based on the
traditional method of chopping the shoots into small pieces,
bruising with wooden hammers to initiate browning, ‘sweating’
(fermentation) and drying for flavour development (Anon,
1985). Steam pasteurisation has been introduced in the 1980s to
ensure good microbial quality after Salmonella contamination
was found.
A study carried out on processing showed that quality and
product consistency could be improved by carrying out
fermentation and drying under controlled conditions (Joubert,
1994, 1998; Joubert and De Villiers, 1997; Joubert and Müller,
1997). A factory-based process is, however, not feasible due to
the economics of scale and the need for artificial heat generation
during drying as opposed to natural heat supplied by sunlight.
Observations made by producers and technical personnel of the
then Rooibos Tea Board suggest that factors such as the
presence of young growth, the age of the bush and the
cultivation area could affect the tea quality (Joubert, 1994).
Chemical changes during fermentation are responsible for
the development of the red-brown colour (Section 5). Recent
papers by Krafczyk and Glomb (2008) and Krafczyk et al.
(2009) provide greater understanding of the conversion of
aspalathin, previously studied by Koeppen and Roux (1965)
and Marais et al. (2000). Aspalathin is not only converted to
flavanones as intermediate products, flavones and a dimer, but
these constituents are minor products among uncharacterised
brown material. Apart from the substantial losses in nothofagin
(Joubert, 1996) no other chemical changes during fermentation
have been studied yet.
When processing green rooibos, the unfermented product,
the greatest challenge is to prevent or to minimise oxidative
changes so that the green colour and aspalathin are retained.
This could be achieved by inactivation of enzymes, for
example, by subjecting the tea to a rapid steaming process.
Alternatively, low temperatures and water activity or exclusion
of oxygen during drying can be used to slow down the rate of
the chemical reactions. A patented vacuum-drying process (De
Beer and Joubert, 2002) produced a good quality product with a
long shelf-life. Samples stored in a dry, dark place were still
green after 2 years (unpublished data). Since vacuum-drying is
carried out batch-wise and is expensive, its use did not extend
past short-term pilot production of green rooibos. One of the
techniques, employed by industry, is to spread the tea in a thinlayer in the sun to facilitate rapid drying. Under these
conditions, production of good quality green rooibos remains
a challenge. If not properly dried, slow browning of the tea will
take place during storage and transport to overseas markets,
resulting in a product with the appearance of a poorly fermented
rooibos, yet without its sought-after characteristic slightly sweet
flavour.
7.2. Extracts
Waste material in the form of coarse stems and uncut leaves
that were sieved out and of no commercial value served as the
stimulus of a study carried out in the early 1980s that led to the
development of an instant rooibos from the fermented plant
material (Joubert, 1984). The idea was also to provide the
consumer with rooibos in a more convenient form (Joubert,
1988a) as brewing of a strong cup of tea at that stage was a time-
consuming process. Low recovery of soluble solids from the
waste (8.9% versus 20.4% for the sieved fractionb10 mesh) and
overproduction (see Section 3) soon shifted the focus to the tea
fraction used for commercial purposes (Joubert, 1984, 1988a).
The concept of a soluble rooibos product only found
commercial application in 2000 in South Africa with the
production of powdered extracts for the beverage, food and
dietary supplement markets (Section 5).
The effect of factors such as extraction temperature and time,
tea-to-water ratio and extraction process (stirred batch-wise and
fixed-bed with flow through) on the recovery of soluble solids
and their phenolic composition were investigated (Joubert,
1988a, 1990a,b; Joubert and Hansmann, 1990). Enzyme
treatment of the plant material was shown to increase the
yield of soluble solids (Pengilly et al., 2008). Normally a muddy
brown precipitate forms upon cooling of the extract after
concentration. This precipitate was found to impair clarity of the
reconstituted extract at ‘cup of tea’ strength. Its removal
improved the clarity, but decreased the phenolic content of the
final product (Joubert, 1990c). Enzyme treatment of rooibos
before extraction could improve the solubility and clarity of re-
constituted rooibos extract (unpublished data). Powdered
rooibos extract is not yet ‘instant’ and agglomeration is required
to achieve the characteristics of an instant product, i.e. no
lumping when added to hot water and quick dispersal with
minimum agitation in the cup (Joubert, 1988b).
Information on the technological processes involved in green
tea extract production is not readily available, except when the
process is patented. Section 5 provides some discussion on the
types of extracts available from green rooibos.
8. Tea quality aspects
The current South African regulations relating to quality
standards for rooibos deal with moisture content, pesticide
residues, microbial contamination and the percentage of white
stems allowed (Anon, 2002). Taste, aroma and colour are dealt
with in vague, meaningless terms, i.e. rooibos should ‘have the
clean, characteristic taste and aroma and clear, distinctive colour
of rooibos’, without definitions or reference standards for the
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Fig. 5. Variation of aspalathin (A) and orientin (B) content (g/100 g dry matter)
in leaves of 21 plants harvested at the same time from a single plantation
(aspalathin ♦ data from Joubert et al., 2008c; orientin ♦ unpublished data).
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by industry is ‘typical’. This means that manufacturers have the
freedom to set their own quality standards in terms of colour,
flavour and mouth feel of rooibos infusions. Furthermore, the
quality classifications ‘Super’ and ‘Choice’ only have meaning
within the context of a specific retail brand.
In the past the ‘caffeine-free’ status and ‘low tannin content’
of rooibos formed the basis of its ‘good-for-you’ message to
consumers. Presently, the antioxidant activity of rooibos, in
addition to its pleasant flavour, contributes to its popularity on
the international markets. However, rooibos is competing in a
market cluttered with products ‘rich in antioxidants’ or a market
characterised by re-positioning of existing products such as the
South American herbal tea, yerba mate, with a high caffeine
content. A quick survey of scientific literature during the past
5 years will show that the number of papers dealing with plant
extracts, whether from fruits or herbs, and their antioxidant
activity have increased dramatically. A number of studies
included rooibos for comparative purposes and several
concluded that their extracts have higher antioxidant activity
than rooibos (e.g. Ivanova et al., 2005; Piccinelli et al., 2004;
Yoo et al., 2009). In the face of such competition, rooibos tea
quality should therefore take on a new meaning (Sections 8.1
and 8.2).
8.1. Sensory quality
For descriptors of rooibos sensory properties to have any
value, ‘characteristic’, ‘typical’ and ‘distinctive’ must have the
same meaning for all role players in the rooibos industry,
including the global industry. For this reason a flavour and
mouthfeel wheel, which incorporates both positive and negative
sensory attributes, totalling 17 descriptors, was developed for
rooibos (Anon, 2011b). A large number of samples was
analysed to derive the final, most frequently occurring,
descriptors. Fine-tuning of the wheel by including data from a
second harvest season is in progress. To aid interpretation of the
descriptors a preliminary sensory lexicon for some of the
descriptors has also been developed (Koch, 2011). A sensory
lexicon is a set of words that describe the sensory attributes of a
product, along with definitions and/or reference standards for
clarification (Drake and Civille, 2002).
The sensory wheel will provide better understanding and
appreciation for rooibos sensory characteristics. This will create
opportunities for niche products with specific flavours such as
estate teas, or teas originating from a specific area as climatic
and soil conditions could contribute to different dominant
flavour nuances, e.g. caramel or floral.
8.2. Other quality parameters
The rooibos industry is increasingly interested in using
polyphenol content and antioxidant activity for marketing
purposes, as well as for quality control of extracts for the
nutraceutical and cosmeceutical markets. Large variation in the
antioxidant activity of different production batches of rooibos
could, however, erode customer confidence in the product,especially customers who are interested in producing value-
added products such as rooibos extract powders that should
meet a predetermined antioxidant activity level. By grading
rooibos based on composition and/or antioxidant activity levels,
marketers would be able to guarantee minimum levels and
product consistency. Producers would be able to blend different
batches to reach a predetermined antioxidant level. Against this
background, three potential objective quality parameters, i.e.
water-soluble solids content, total antioxidant capacity (TAC)
and total polyphenol content (TPC) are currently under
investigation by the ARC.
Two of the prominent South African extract producers use
TPC and TAC as indicators of quality. A major extract
manufacturer also produces an extract standardised on orientin
and isoorientin content (N0.5% total), while an extract of
fermented rooibos, standardised on aspalathin content, is under
development (D. Malherbe, Afriplex, Paarl, South Africa; pers.
comm.).
Many researchers have shown that for a specific type of
product various antioxidant assays correlate well with TPC (e.g.
Prior et al., 2005). Very good correlations between TPC and
ABTS•+ scavenging activity were also obtained for unfermen-
ted rooibos water extracts (r=0.99; Joubert et al., 2008b).
Interestingly, aspalathin content of unfermented rooibos water
extracts was also highly correlated with ABTS•+ scavenging
activity (r=0.96; Joubert et al., 2008b).
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is especially important to be careful of directly comparing
antioxidant results from different sources as differences in assay
protocol between studies can have a large influence on the
values obtained. A myriad assays are available for determining
the antioxidant activity of foods and beverages. Prior et al.
(2005) reviewed the assays most commonly used for analysis of
foods and dietary supplements and suggested the ORAC
(Oxygen Radical Absorbance Capacity) (Ou et al., 2001),
ABTS•+ scavenging (Re et al., 1999) and Folin-Ciocalteau
(Singleton and Rossi, 1965) assays based on their advantages
and disadvantages. Generally the ORAC assay is favoured by
the American nutraceutical industry to ‘quantify’ the total
antioxidant capacity of extracts (Crawford, 2011).
8.3. Plant material
The composition of the plants has a direct effect on the
quality of processed fermented tea and commercial extracts.
Rooibos plants are cultivated from seedlings, causing large
variation in phenolic composition between plants. As an
example the aspalathin and orientin content of rooibos leaves
harvested at the same time from 21 individual plants in the same
plantation is shown in Fig. 5A (data adapted from Joubert et al.,
2008c) and 5B (unpublished data), respectively. The aspalathin
and orientin content ranged from 6.0 to 11.2 g/100 g dry matter
and 0.5 to 1.1 g/100 g dry matter, respectively. Harvest date is
another factor that could influence phenolic composition of
rooibos plants. The aspalathin content of plant material harvested
from the same plants ranged from 2.33 to 3.76 g/100 g dry matter
over a one year period (unpublished data).
The phenolic composition of wild rooibos showed qualita-
tive and quantitative variation between populations and types
(Van Heerden et al., 2003). Some populations even lacked
aspalathin, the major flavonoid in the red type or Rocklands
type of A. linearis used for commercial production. One of
the wild types, lacking aspalathin, contained rutin as majorFig. 6. Anti-ageing effect of rooibos on the human skin. Cartoon originally publis
Landbouweeklblad).flavonoid (Joubert and Schulz, 2006). If the presence of
aspalathin in the plant material (green and fermented) becomes
part of the quality parameters of a rooibos GI (Section 4) then
some wild rooibos types may be excluded from the ‘rooibos’
label in future.
8.4. Commercial extracts
Recently, changes in quality of extracts during the
manufacturing process were investigated in terms of aspalathin,
orientin, isoorientin and total polyphenol contents (Joubert
et al., 2009b; Viljoen, 2008). No major losses of aspalathin,
orientin or isoorientin were observed during microfiltration,
reverse osmosis and concentration of fermented rooibos extract.
The total polyphenol content, on the other hand, seemed to
increase during these processes (Viljoen, 2008) indicating that
compounds other than polyphenols are removed during the
production process. Spray-drying of the concentrate did not
affect its phenolic content.
8.5. Ready-to-drink iced teas
Ready-to-drink rooibos iced tea is a popular variant in South
Africa; however, its rooibos content is not regulated. A recent
study (Joubert et al., 2009b) found that some brands contained no
aspalathin or its oxidation products, orientin and isoorientin,
suggesting that no rooibos extract was used in their manufacture.
The maximum aspalathin content found in 41 samples,
representing eight brands, was 0.69 mg/100 mL. The average
aspalathin content of the samples was 0.28 mg/100 mL, which
was much lower than that expected in rooibos extract
reconstituted to ‘cup of tea’ strength (0.3–0.9 mg/100 mL;
n=20; unpublished data).
In an attempt to understand the low levels of rooibos
flavonoids in commercial iced teas, a study was conducted to
assess their stability in fermented (Joubert et al., 2009b) and
green (Joubert et al., 2010c) rooibos iced tea formulationshed in Landbouweekblad of 6 March 1992 (reproduced with permission from
Table 5
Summary of in vitro and in vivo studies on the bioactivity of rooibos infusions or extracts published after the review of Joubert et al., 2008a.
Bioactivity Infusion/ extract Model Outcome Reference
Regeneration of
liver damage
Fermented a aq. extract CCl4-induced liver damage in rats Reduced activity of ALT and AST;
reduced total bilirubin;
reduced fibrotic tissue
Uličná et al.,
2008
Anti-inflammatory
activity
Unfermented aq. extract Wistar rat DSS-induced colitis Increased SOD levels;
decreased 8-hydroxy-2′-
deoxyguanosine levels
Baba et al.,
2009
Chemoprotection Unfermented and
fermented aq. infusions
Oral administration to Fischer rats;
cancer promotion and initiation by
FB1 and DEN, respectively
Fermented tea decreased lipid
peroxidation in liver;
unfermented tea reduced total
number if foci and relative
amount of large foci; both teas
decreased plasma GSH
levels; fermentation reduced
chemoprotective activity
Marnewick
et al., 2009
Tumouricidal
activity
Fermented a EtOH extract Murine neuroblastoma cell line
derived from a spontaneous
malignant tumour
Weak activity based on LC50N
5 mg/mL
Mazzio and
Soliman, 2009
PPARγ ligand
binding activity
Fermented a DMSO extract Polar Screen PPARγ
ligand-binding
competitive assay
Moderate ligand-binding activity Mueller and
Jungbauer,
2009
Lantha Screen TR-FRET PPARγ
coactivator assay
Strong antagonist of coactivator
recruitment to PPARγ
Mueller and
Jungbauer,
2009
Transactivation activity using a
chimeric GAL4- PPARγ assay
No transactivation activity Mueller and
Jungbauer,
2009
Inhibition of
adrenal
steroidogenic
P450 enzymes
Fermented and
unfermented aq. and
MeOH extracts
Inhibition of substrate binding assay
to CYP17 and CYP21 in adrenal
microsomes
Competitive inhibition; unfermented
MeOH extract more
effective than fermented MeOH extract
Perold, 2009
Inhibition of substrate metabolism in
COS1 cells expressing baboon
CYP17 or CYP21
Stronger inhibition of CYP21;
fermented weaker than
unfermented
Perold, 2009
Anti-carcinogenic
and
photoprotective
effect
Unfermented and
fermented EtOH extracts
Two-stage skin carcinogenesis
mouse model; UVB and DMBA as
promotor and intiator, respectively
Reduced incidence and
volume of tumours; reduced reduced
erythema, peeling, oedema and
hyperplasia; depletion of
catalase and SOD prevented;
reduced oxidative and direct
DNA damage; reduced lipid
peroxidation; reduced
induction of COX-2 and ODC
Petrova, 2009
Oxidative stress
reduction
Fermented a aq. infusion Single oral dose to healthy humans Increased plasma antioxidant
capacity and GSH/GSSH
erythrocyte ratio
Wanjiku, 2009
Cytoprotective
activity
Fermented a 70% aq.
MeOH extract
Chinese hamster lung fibroblast
V79-4 cells
Reduced H2O2 induced cell
membrane damage;
reduced intracellular ROS generation
Yoo et al.,
2009
Anti-wrinkle
activity
Commercial extract
blend with Camellia
sinensis extract
Topical application to humans
(female)
Reduced wrinkles; no effect
on skin smoothness,
scaliness and roughness
Chuarienthong
et al., 2010
Inhibition of
post-prandial
oxidative stress
Fermented aq. infusion Single oral dose containing sugar
with a high fat meal to
healthy humans
Reduced plasma glucose,
insulin, total cholesterol, LDL
cholesterol, triglycerides,
hsCRP, CD and TBARS levels;
increased plasma antioxidant
capacity and total glutathione
level
Francisco,
2010
Promotion of hair
growth
Blend of botanical
extracts containing
unfermented rooibos
Topical application to
humans (male)
with androgenetic alopecia
(male pattern baldness)
Increased hair density,
number of anagen follicles and
hair growth rate
Glynn, 2010
Anti-inflammatory
activity
Fermented a aq. infusion Whole blood culture assay;
unstimulated, endotoxin
Increased secretion of IL-6, IL-10,
and IFNγ in unstimulated
Hendricks and
Pool, 2010
(continued on next page)
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Table 5 (continued)
Bioactivity Infusion/ extract Model Outcome Reference
stimulated and PHA
stimulated
cells; increased IL-6, decreased
IL-10 and no change for
TNFγ secretion in stimulated cells
Hypoglycaemic
activity
Fermented aq. extracts
and aspalathin-enriched
unfermented extracts
STZ-induced hyperglycaemic
Wistar rats
Lowered blood glucose levels Joubert et al.,
2010b
Fermented aq. extract Diet-induced type II diabetic
vervet monkeys
Lowered blood glucose levels Joubert et al.,
2010b
Anti-inflammatory
activity
Fermented a DMSO
extract
LPS-stimulated macrophages Reduce secretion of IL-6 and IL-10;
increased expression of
COX-2; no effect on TNFα
secretion and iNOS expression
Mueller et al.,
2010
Angiotensin-
converting
enzyme
inhibition
Fermented a aq. infusion Single oral dose to healthy
humans
Inhibited ACE activity for
the ACE II genotype;
no effect on nitric oxide
concentration
Persson et al.,
2010
Rehydration Fermented a aq. infusion Oral administration to
humans after 2 h wrestling
practice
Rehydration due to rooibos
comparable with water control
Utter et al.,
2010
Oxidative stress
reduction and
lipid profile modulation
Fermented and
unfermented aq.
extracts in ready-to-drink
beverage
Single oral dose to healthy
humans
Increased plasma antioxidant
capacity; no change in lipid
profile or uric acid level
Villaño et al.,
2010
Anti-hyperlipidaemic
activity
Fermented a aq. extract Hyperlipidaemic male
LDLr−/− mice
Reduced serum cholesterol,
triglyceride and free
fatty acid levels;
prevention of dietary-induced
hepatic steatosis
Beltran-Debon et
al., 2011
Anti-adipogenesis
activity
Fermented a aq. extract 3T3-L1 mouse adipocytes Dose-dependent inhibition
of triglyceride accumulation
Beltrán-Debón et
al., 2011
Oxidative stress reduction and
lipid profile modulation
Fermented aq. infusion Oral administration to
humans with
cardiovascular risk
factors over a 6 week
period
Decreased CD, TBARS, LDL
cholesterol and
triacylglycerols levels;
increased GSH level,
GSH/GSSG ratio and
HDL cholesterol
Marnewick et al.,
2011
aq., aqueous; ACE, angiotensin-converting enzyme; ALT, alanine aminotransferase; AST, aspartate aminotransferase; CD, conjugated dienes; COX, cyclooxygenase;
DEN, diethylnitrosamine; DMBA, 7,12-dimethylbenz[a]anthracene; DMSO, dimethylsulphoxide; DSS, dextran sodium sulphate; EtOH, ethanol; FB1, fumonisin B1;
GSH, reduced glutathione; GSSG; oxidised glutathione; HDL, high-density lipoprotein; hsCRP, high sensitive C-reactive proteins; IFN, interferon; IL, interleukin;
iNOS, inducible nitric oxide synthase; LC50, concentration needed to kill 50% of cells; LDL, low-density lipoprotein; LPS, lipopolysaccharide; MeOH, methanol;
ODC, ornithine decarboxylase; PHA, phytohemagglutinin; PPAR, peroxisome proliferators-activated receptor; SOD, superoxide dismutase; STZ, streptozotocin;
TBARS, thiobarbituric acid reactive substances; TNF, tumour necrosis factor; UVB, ultraviolet B light.
a Fermentation state of plant material used is not specified, but fermented tea is assumed as this is the form most commonly sold.
880 E. Joubert, D. de Beer / South African Journal of Botany 77 (2011) 869–886during heat treatment. Pasteurisation or sterilisation is the most
likely processing step during the manufacture of rooibos iced
teas that could decrease their flavonoid content. Pasteurisation
caused no loss of rooibos flavonoids in fermented rooibos iced
tea, but sterilisation markedly decreased the aspalathin and
isoorientin contents (Joubert et al., 2009b). The presence of
citric and ascorbic acids partially protected against the loss of
aspalathin and isoorientin. Orientin showed different trends due
to its conversion from isoorientin. The aspalathin content of
iced tea could be greatly increased by using an aspalathin-
enriched extract produced from green rooibos (Joubert et al.,
2010c). Trends for heat stability of the flavonoids in this type of
rooibos iced tea were similar to that of fermented rooibos iced
tea. Combining the aspalathin-enriched green rooibos extract
with ascorbic acid in a nano-micelle carrier system increased the
heat stability of the resulting iced tea formulation with only a
minor reduction in aspalathin loss after addition of citric acid.Results from these two studies show that rooibos iced tea could
make a valuable contribution to aspalathin intake if care is taken
during formulation and processing. The bioavailability of
aspalathin when present in a ready-to-drink rooibos iced tea
was recently demonstrated (Section 9).
Storage of iced tea can also contribute to low levels of
aspalathin. Its stability during storage was shown to depend on
product formulation and type of extract (Viljoen, 2008). pH was
shown to be a crucial factor in its stability (De Beer et al., 2011).
Milk-based products with a relatively high pH would not retain
aspalathin.
9. Food or medicine conundrum
The discovery by A. Theron in 1968 that rooibos helped to
soothe her allergic baby's colic started off rooibos tea's
reputation as a ‘healthy drink’ in modern times (Joubert and
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the Rooibos Tea Control Board on 18 May 1968, was met with
scepticism from scientists who were approach for comment.
More anecdotal evidence became evident after newspaper
reports and radio interviews and today the therapeutic value of
rooibos for colic babies is well-known.
In the 1985 Annual Report of the Rooibos Tea Board (Anon,
1985) it was noted that: ‘Rooibos Tea is used overseas mainly
for its medicinal value and has thus become popular as a
medicine rather than a tea. This is to a certain extent the main
reason why overseas marketing potential of Rooibos Tea is
rather limited.’ Changing consumer attitudes and the focus on
‘anti-ageing’ soon afterwards placed rooibos in a position to
exploit its health-promoting properties, and particularly its
antioxidant activity in marketing (Wilson, 2005).
Japanese researchers were the first to study the antioxidant
and ‘anti-ageing’ properties of rooibos. A cartoon was
published in March 1992 in the Landbouweekblad, a weekly
farmers’ magazine, after much had been made locally of the
‘anti-ageing’ effect of rooibos on the skin (Fig. 6). In the cartoon
Rooibos Tea Board stalwarts, J. van Putten, Deputy General
Manager (Export Promotion), dressed as a nanny and pushing
P. Saayman, the General Manager, in a baby stroller, calls to the
flabbergasted secretary to phone Japan to inform them that the
‘anti-ageing’ effect had worked. The logo of the Rooibos TeaTable 6
Summary of studies on in vitro and in vivo absorption, metabolism and transport of
Characteristic Test sample Model Outc
Transport across
skin
Aspalathin-enriched
unfermented extract;
aspalathin
Human abdominal skin in
Franz diffusion cells
Low
Transport across
intestinal
epithelial cells
Aspalathin-enriched
unfermented extract;
aspalathin
Caco-2 cell monolayers Fast
trans
Absorption and
metabolism
Aspalathin-enriched
unfermented extract
Oral administration to pigs
over an 11 day period
Aspa
gluc
and
iden
Hepatic and
intestinal
methylation
Aspalathin Metabolism in rat liver and
intestinal cytosolic fractions
with cofactors
Two
intes
Absorption and
metabolism
Unfermented aq. drink Single dose oral
administration to humans
One
iden
Absorption and
metabolism
Unfermented and fermented
aq. extracts in ready-to-drink
beverage
Single dose oral
administration to humans
Eigh
meta
urine
Hepatic
metabolism
Aspalathin; nothofagin Metabolism in rat liver
microsomal and cytosolic
fractions with cofactors
Two
meta
obse
gluc
HPL
Absorption and
metabolism
Unfermented aq. drink and
aspalathin-enriched fraction
dissolved in water
Single dose oral
administration to humans
Six a
meth
agly
(gluc
noth
eriod
unm
aq, aqueous.Board, symbolising a cup of rooibos tea with steam rising,
forms the baby stroller. Since then many studies on the potential
health-promoting properties of rooibos have been carried out in
South Africa and Europe (Joubert et al., 2008a). The latest
studies are summarised in Table 5.
Human studies dealing with the health promoting aspects of
rooibos and the bioavailability of rooibos flavonoids, especially
aspalathin, have been limited to date and are summarised in
Joubert et al. (2008a) and Tables 5,6 and 7. For a compound to
exert an effect in vivo, it should reach the target tissue(s). In the
first instance the presence of the compound in the plasma or
urine is essential. Since the study of the bioavailability of
aspalathin in the pig as model (Kreuz et al., 2008), new insights
into the bioavailability of aspalathin and other rooibos
flavonoids have been gained by the studies of Courts and
Williamson (2009), Stalmach et al. (2009) and Breiter et al.
(2011). Aspalathin is extensively metabolised and phase II
metabolites have been found in the urine (Table 6). Most of the
metabolites were excreted in the urine of volunteers within 5 h
of consuming 500 mL of rooibos ready-to-drink beverages
(Stalmach et al., 2009). Kreuz et al. (2008), feeding pigs a high
concentration of aspalathin-enriched green rooibos extract,
found only trace quantities of the unmetabolised compound in
the plasma. Its presence was recently confirmed in human
plasma (Breiter et al., 2011). All of the studies showed poorrooibos flavonoids.
ome Reference
level of permeation through skin and distribution in skin layers Huang et al.,
2008b
, concentration-dependent transport of aspalathin; higher
port from extract than pure aspalathin
Huang et al.,
2008b
lathin and five metabolites (O-methylated and/or
uronidated aspalathin, a glucuronidated aglycone of aspalathin
a O-methylated and glucuronidated eriodictyol metabolite)
tified in urine; no metabolites detected in plasma
Kreuz et al.,
2008
methylated metabolites identified with higher rate for
tinal cytosolic fraction
Courts and
Williamson,
2009
methylated and one methylated-glucuronidated metabolite
tified in urine
Courts and
Williamson,
2009
t metabolites (O-linked methyl, sulfate, and glucuronide
bolites of aspalathin and an eriodictyol-O-sulfate) identified in
; no metabolites detected in plasma
Stalmach et
al., 2009
aspalathin and two nothofagin monoglucuronidated
bolites observed; one sulphated aspalathin metabolite
rved; no sulphated nothofagin metabolites observed; aspalathin
uronidated metabolites had no antioxidant activity in
C-ABTS•+ or -DPPH• scavenging assays
Van der
Merwe et al.,
2010
spalathin metabolites (methylated, glucuronidated,
ylated-glucuronidated and sulphated), three aspalathin
cone metabolites (glucuronidated), one nothofagin metabolite
uronidated), as well as unmetabolised aspalathin and
ofagin, detected in urine; aspalathin, orientin, isoorientin, (S)-
ictyol-8-C-glucoside, vitexin and an isomer of rutin detected
etabolised in plasma
Breiter et al.,
2011
Table 7
Summary of in vitro and in vivo studies on the bioactivity of the major rooibos flavonoids–aspalathin, orientin and isoorientin.
Bioactivity/
pharmacological
property
Model Outcome Reference
Aspalathin
Anti-mutagenicity Salmonella typhimurium assay; tester strain/mutagen
combinations TA98/2-AAF and TA100/AFB1;
with and without metabolic activation
Moderate anti-mutagenic effect; no clear dose–response effect;
no mutagenic or comutagenic effect
Snijman et al.,
2007
Hypoglycaemic
activity
Cultured L6 myotubes Increased glucose uptake Kawano et al.,
2009
RIN-5F pancreatic β-cells Increased insulin secretion Kawano et al.,
2009
Oral administration to db/db mice Dietary intake supressed fasting blood glucose levels;
improved glucose tolerance
Kawano et al.,
2009
Hypoglycaemic
activity
STZ-induced hyperglycaemic Wistar rats Aspalathin in combination with rutin, but not alone,
lowered blood glucose levels
Joubert et al . ,
2010a,b
Phytoestrogenicity ECOLOGIENA® Estrogen (E1/E2/E3) ELISA kit Moderate phytoestrogenicity Shimamura et al.,
2006
Orientin
Anti-mutagenicity Salmonella typhimurium assay; tester strain/mutagen
combinations TA98/2-AAF and TA100/AFB1;
with and without metabolic activation
Typical dose-response anti-mutagenic effect against AFB1;
effect against 2-AAF similar to that of aspalathin;
no mutagenic or comutagenic effect
Snijman et al.,
2007
Anti-adipogenesis
activity
3T3-L1 mouse adipocytes Inhibited adipogenesis; decreased C/EBPα and PPARγ
protein expression; vitexin also active
Kim et al., 2010
Inhibition of adrenal
steroidogenic P450
enzymes
COS1 cells expressing baboon CYP21 Inhibited CYP21 Perold, 2009
Isoorientin
Anti-mutagenicity Salmonella typhimurium assay; tester strain/mutagen
combinations TA98/2-AAF and TA100/AFB1;
with and without metabolic activation
Typical dose-response anti-mutagenic effect against AFB1;
more effective against 2-AAF than aspalathin;
no mutagenic or comutagenic effect
Snijman et al.,
2007
Hypoglycaemic and
anti-
hyperlipidaemic
activity
Subacute oral administration to STZ-induced diabetic
rats
Reduced fasting blood glucose, cholesterol and
triglyceride levels
Sezik et al., 2005
Anti-inflammatory
activity
Oral administration in mice; carageenan-induced
pleurisy model
Inhibited leukocytes and neutrophils Zucolotto et al.,
2009
Ant i - in f lammatory
activity
Single oral dose in mice; carrageenan-induced hind
paw edema model
Inhibited inflammation without inducing gastric damage Küpeli et al., 2004
Anti-nociceptive
activity
Single oral dose in mice; p-benzoquinone-induced
abdominal constriction model
Reduced number of writhings Küpeli et al., 2004
Gastroprotective
activity
Single oral dose in mice; EtOH-induced
ulcerogenesis model
No activity Küpeli et al., 2004
Hepatoprotective
activity
CCl4-induced hepatotoxicity in rats Reduced MDA and GSH levels in tissue and MDA, ALT and
AST levels in plasma
Deliorman Orhan
et al., 2003
2-AAF, 2-acetamido-fluorene; AFB1, aflatoxin B1; ALT, alanine aminotransferase; AST, aspartate aminotransferase; C/EBP, CCAAT-enhancer-binding protein;
EtOH, ethanol; GSH, reduced glutathione; MDA, malondialdehyde; PPAR, peroxisome proliferators-activated receptor; STZ, streptozotocin.
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bioactivity, e.g. glucose-lowering effect, confirm the impor-
tance and relevance of this rooibos flavonoid (Table 7).
The finding that the plasma antioxidant status of the
volunteers drinking the ready-to-drink rooibos beverage peaked
after 1 h (Villaño et al., 2010) may explain why Sauter (2004)
showed no improvement in the plasma antioxidant status of
volunteers dosed with aspalathin-enriched extract. In the latter
study, the volunteers received a twice daily dose of 250 mg of
aspalathin-enriched green rooibos extract for 2 weeks. In this
case the blood was sampled the day after the last dose.
Conjugation of aspalathin would also impair its ability to act as
antioxidant in the plasma (Van der Merwe et al., 2010).Marketing of rooibos as an ‘antioxidant’ beverage may need
reviewing because of the over-supply of natural antioxidant
products on the market. The market is constantly searching for
new products that have more to offer than just high antioxidant
activity and modulation of oxidative stress. Markets are moving
towards condition-specific antioxidants, especially those aimed
at inflammation (Crawford, 2011).
Two incorrect nutritional ‘facts’ that need highlighting and
that some companies use in their promotional literature and on
their web pages, are the erroneous claims that rooibos has a high
ascorbic acid and mineral content. Hesseling et al. (1979)
incorrectly interpret the apparently high ascorbic acid content of
the infusion obtained using a method that is not specific for
883E. Joubert, D. de Beer / South African Journal of Botany 77 (2011) 869–886ascorbic acid (Joubert et al., 2008a). Unfortunately, Morton
(1983) repeated this high value in her review paper on rooibos,
an incorrect statement which even now is still recurring in some
promotional material. Furthermore, the same paper by Morton
(1983) reported highly inflated values for the iron, calcium,
magnesium, phosphate and potassium content of rooibos.
Statements about the ‘isotonic’ value of rooibos have also
been made. This has not been challenged in the scientific
literature until recently. Joubert et al. (2008a) reported that a 5-
min infusion of rooibos at ‘cup-of-tea’ strength contains only
traces of iron, with the iron content only 15% of that reported by
Morton (1983). The content of other minerals was also
substantially lower than previously reported. Malik et al.
(2008), after determining the mineral content of a 15-min
infusion reported similar values to Joubert et al. (2008a). They
came to the conclusion that rooibos is not a valuable source of
nutrient minerals as claimed in promotional material of some
marketing companies. With the establishment of SARC,
dissemination of new findings relating to the potential health-
benefits of rooibos is handled in a responsible manner. Yet, in
spite of these efforts by SARC, inflated claims about this herbal
tea still abound in promotional material of companies.
10. Future challenges and opportunities
The future challenges and opportunities of the rooibos
industry are succinctly summarised by the following conclusion
reached by the recent Rooibos and Honeybush Market
Development Programme Framework report (Anon, 2010)
after inputs of various industry stakeholders: ‘An integrated
global marketing drive based on the scientific proof of health
claims, together with innovative, value-added product applica-
tions and a sound pricing system, could be the beginning of an
extraordinary bright future for the Rooibos industry’.
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